Iovance Biotherapeutics (IOVA) Highlights Updated Clinical Data for Tumor Infiltrating Lymphocyte Therapy Lifileucel in Advanced Melanoma

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/22/2026

1. SPCX
2. NVDA
3. ACN
4. USO
5. DFTX
6. GOOGL
7. APGE
8. MU
9. IBM
10. HOOD

Go back to Iovance Biotherapeutics (IOVA) Highlights Updated Clinical Data for Tumor Infiltrating Lymphocyte Therapy Lifileucel in Advanced Melanoma
(NASDAQ: IOVA) Delayed: 4.06 +0.15 (3.84%)
Previous Close $3.91    52 Week High $ 
Open $3.92    52 Week Low $ 
Day High $4.20    P/E N/A 
Day Low $3.91    EPS $ 
Volume 11,605,590